1040: What Huge Cuts To NSF Funding Mean For Science

Grant funding by the National Science Foundation has been cut by more than half this year, bringing the foundation’s science funding to its lowest level in decades. Katrina Miller, who covers science for the New York Times, joins Host Flora Lichtman to unpack the cutbacks and discuss where the funding changes might lead.And, the FDA has cleared a blood test to help diagnose Alzheimer’s disease. The first-of-its-kind test measures the levels of amyloid and tau proteins in a patient’s blood, two major biomarkers of the disease. Alzheimer’s researcher Jason Karlawish joins Flora to explain this new diagnostic tool and what it means for patients.Guests:Katrina Miller is a science reporter for The New York Times based in Chicago.Dr. Jason Karlawish is a professor of medicine, medical ethics and health policy, and neurology at the University of Pennsylvania’s Perelman School of Medicine, and co-director of the Penn Memory Center, based in Philadelphia, Pennsylvania.Transcripts for each segment will be available after the show airs on sciencefriday.com.Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.